09 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/09/2859816/0/en/ANI-Pharmaceuticals-Announces-the-Launch-of-Baclofen-Oral-Suspension.html
10 Jan 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217788
18 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/allos-pharma-inc-expands-intellectual-property-rights-for-arbaclofen-301930753.html
10 Aug 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216309
08 Jun 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217252
22 May 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/05/22/2673311/0/en/Rhythm-Pharmaceuticals-and-Genpharm-Announce-Collaboration-to-Provide-IMCIVREE-setmelanotide-to-Patients-in-Gulf-Cooperation-Council-Countries.html